No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN250117C690000
- 20.20
- -9.90-32.89%
15min DelayTrading Jan 13 12:21 ET
20.20High10.75Low
10.75Open30.10Pre Close14 Volume47 Open Interest690.00Strike Price21.07KTurnover54.06%IV1.71%PremiumJan 17, 2025Expiry Date8.26Intrinsic Value100Multiplier4DDays to Expiry11.94Extrinsic Value100Contract SizeAmericanOptions Type0.6385Delta0.0093Gamma33.65Leverage Ratio-2.0024Theta0.0478Rho21.49Eff Leverage0.2790Vega
Intraday
- 5D
- Daily
News
Live On CNBC, Rob Sechan Announces Sold Regeneron
Express News | Regeneron Pharmaceuticals Inc : Jefferies Cuts Target Price to $1,120 From $1,200
Citigroup Cuts Regeneron Pharmaceuticals' Price Target to $795 From $895
Regeneron Announces IPR&D Charges
4D Molecular Downgraded at BMO on Limited Population for Wet AMD Candidate
Regeneron Pharmaceuticals Met Primary Endpoint in Cell Carcinoma Treatment Trial